Skip to main content

Interactions between Ferric derisomaltose and Vitagen Forte

1 drug interaction and 3 additional warnings found for the following 2 drugs:

Add/remove drugs

Drug interactions

Moderate drug interactions

Moderate:

multivitamins with iron ferric derisomaltose

Applies to: Vitagen Forte (multivitamin with iron) and ferric derisomaltose
Generally avoid

Parenteral iron therapy may reduce the absorption of concomitantly administered oral iron preparations.

Management

Parenteral iron preparations should not be administered concomitantly with oral iron preparations. Patients should wait at least 5 days after stopping parenteral iron therapy before taking oral iron supplements.

References (5)
  1. "Product Information. Infed (iron dextran)." Schein Pharmaceuticals Inc
  2. (2001) "Product Information. Ferrlecit (sodium ferric gluconate complex)." sanofi-aventis
  3. (2001) "Product Information. Venofer (iron sucrose)." American Regent Laboratories Inc
  4. (2009) "Product Information. Feraheme (ferumoxytol)." Alza Pharmaceuticals
  5. (2021) "Product Information. Accrufer (ferric maltol)." Shield Therapeutics

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition.

It can be intentional, when combining drugs with similar actions adds demonstrated therapeutic benefit — or unintentional, such as when a patient sees multiple prescribers or fills prescriptions at more than one pharmacy, which can lead to adverse effects.

Duplication:

Iron preparations

The recommended maximum number of medicines in the 'iron preparations' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'iron preparations' category:

  • ferric derisomaltose
  • Vitagen Forte (multivitamin with iron)

Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.

Food/lifestyle interactions

Moderate food/lifestyle interactions

Moderate:

multivitamins with iron Food/Lifestyle

Applies to: Vitagen Forte (multivitamin with iron)
Adjust dosing interval

Concomitant use of some oral medications may reduce the bioavailability of orally administered iron, and vice versa. Food taken in conjunction with oral iron supplements may reduce the bioavailability of the iron. However, in many patients intolerable gastrointestinal side effects occur necessitating administration with food.

Management

Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect. Some studies suggest administration of iron with ascorbic acid may enhance bioavailability. In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased. Consult the product labeling for specific separation times and monitor clinical responses as appropriate.

References (2)
  1. "Product Information. Feosol (ferrous sulfate)." SmithKline Beecham
  2. (2021) "Product Information. Accrufer (ferric maltol)." Shield Therapeutics

Disease interactions

1 potential interaction Applies to: 1 condition, including Hemochromatosis.

Hemochromatosis

Moderate:

ferric derisomaltose

Ferric derisomaltose has a moderate potential interaction with Hemochromatosis.

Ferric derisomaltose should not be administered to patients with iron overload.

More resources

ferric derisomaltose

A total of 28 drugs are known to interact with ferric derisomaltose.

Vitagen Forte

A total of 106 drugs are known to interact with Vitagen Forte.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.